Discontinuation of tofacitinib and TNF inhibitors in patients with rheumatoid arthritis: analysis of pooled data from two registries in Canada.

In the univariable survival analysis, patients using TNFi therapy had borderline significant lower discontinuation due to any reason (unadjusted HR=0.83 (95% CI 0.69 to 1.00, p=0.05)) compared with patients using TOFA therapy ( table 2 ).

also in 11,409 other papers